Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products; Guidance for Industry; Draft Guidance
NonrulemakingOtherFDA-2019-D-4964-0077
Comments
0
Awaiting comments
Deadline
90 days
Closes Sep 23, 2026
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from regulations.gov.
Revision 1
- Posted
- Jun 24, 2026
- Comment period
- Jun 24, 2026 – Sep 23, 2026
- Agency
- Food and Drug Administration (FDA)
Analysis
Overview
No comments yet — comment period open · 90 days left.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
No comments match.